|
1
|
Chaudhary K and Khanna R: Biocompatible
peritoneal dialysis solutions: do we have one? Clin J Am Soc
Nephrol. 5:723–732. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Katavetin P, Theerasin Y, Treamtrakanpon
W, et al: Treatment failure in automated peritoneal dialysis and
double-bag continuous ambulatory peritoneal dialysis. Nephrology
(Carlton). 18:545–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cortés-Sanabria L, Paredes-Ceseña CA,
Herrera-Llamas RM, et al: Comparison of cost-utility between
automated peritoneal dialysis and continuous ambulatory peritoneal
dialysis. Arch Med Res. 44:655–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jain AK, Blake P, Cordy P and Garg AX:
Global trends in rates of peritoneal dialysis. J Am Soc Nephrol.
23:533–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chaudhary K, Sangha H and Khanna R:
Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol.
6:447–456. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakthong P and Kasemsup V: Health utility
measured with EQ-5D in Thai patients undergoing peritoneal
dialysis. Value Health. 15:(Suppl). S79–S84. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kwan BC, Chow KM, Ma TK, et al: Automated
peritoneal dialysis in Hong Kong: there are two distinct groups of
patients. Nephrology (Carlton). 18:356–364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guney I, Solak Y, Atalay H, et al:
Comparison of effects of automated peritoneal dialysis and
continuous ambulatory peritoneal dialysis on health-related quality
of life, sleep quality and depression. Hemodial Int. 14:515–522.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Johnson DW, Brown FG, Clarke M, et al:
balANZ Trial Investigators: Effects of biocompatible versus
standard fluid on peritoneal dialysis outcomes. J Am Soc Nephrol.
23:1097–1107. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kaminski M, Frescos N and Tucker S:
Prevalence of risk factors for foot ulceration in patients with
end-stage renal disease on haemodialysis. Intern Med J.
42:e120–e128. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Weinhandl ED, Foley RN, Gilbertson DT, et
al: Propensity-matched mortality comparison of incident
hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol.
21:499–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim S, Oh KH, Chin HJ, et al: Effective
removal of leptin via hemodiafiltration with on-line endogenous
reinfusion therapy. Clin Nephrol. 72:442–448. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marwarha G and Ghribi O: Leptin signaling
and Alzheimer's disease. Am J Neurodegener Dis. 1:245–265.
2012.PubMed/NCBI
|
|
14
|
Mutabaruka MS, Aoulad Aissa M, Delalandre
A, et al: Local leptin production in osteoarthritis subchondral
osteoblasts may be responsible for their abnormal phenotypic
expression. Arthritis Res Ther. 12:R202010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taskapan MC, Taskapan H, Sahin I, et al:
Serum leptin, resistin and lipid levels in patients with end stage
renal failure with regard to dialysis modality. Ren Fail.
29:147–154. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fang TC, Lee CJ, Wang CH, et al: Fasting
serum leptin level correlates with mid-arm fat area in peritoneal
dialysis patients. Ther Apher Dial. 14:583–588. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Briley LP and Szczech LA: Leptin and renal
disease. Semin Dial. 19:54–59. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mak RH, Cheung W, Cone RD and Marks DL:
Leptin and inflammation-associated cachexia in chronic kidney
disease. Kidney Int. 69:794–797. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pérez-Fontán M, Cordido F,
Rodríguez-Carmona A, et al: Plasma ghrelin levels in patients
undergoing haemodialysis and peritoneal dialysis. Nephrol Dial
Transplant. 19:2095–2100. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kaynar K, Kural BV, Ulusoy S, et al: Is
there any interaction of resistin and adiponectin levels with
protein-energy wasting among patients with chronic kidney disease.
Hemodial Int. 18:153–162. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Horwich TB, Kalantar-Zadeh K, MacLellan RW
and Fonarow GC: Albumin levels predict survival in patients with
systolic heart failure. Am Heart J. 155:883–889. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hilkens MG, Netea MG, Van der Meer JW and
Koolen MI: Leptin and proinflammatory cytokines in patients
undergoing peritoneal dialysis. Eur J Clin Invest. 33:525–526;
author reply 527–528. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Howard JK, Lord GM, Clutterbuck EJ, et al:
Plasma immunoreactive leptin concentration in end-stage renal
disease. Clin Sci (Lond). 93:119–126. 1997.PubMed/NCBI
|
|
24
|
Zhang L, Liu J, Xu DM, et al: Clearance
effect of peritoneal dialysis on leptin. J Southeast Univ.
29:539–542. 2010.
|
|
25
|
Tsubakihara Y, Nishi S, Akiba T, et al:
2008 Japanese society for dialysis therapy: guidelines for renal
anemia in chronic kidney disease. Ther Apher Dial. 14:240–275.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zintzaras E and Ioannidis JP: HEGESMA:
genome search meta-analysis and heterogeneity testing.
Bioinformatics. 21:3672–3673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zintzaras E and Ioannidis JP:
Heterogeneity testing in meta-analysis of genome searches. Genet
Epidemiol. 28:123–137. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Song F and Gilbody S: Bias in
meta-analysis detected by a simple, graphical test. Increase in
studies of publication bias coincided with increasing use of
meta-analysis. BMJ. 316:4711998.PubMed/NCBI
|
|
31
|
Peters JL, Sutton AJ, Jones DR, et al:
Comparison of two methods to detect publication bias in
meta-analysis. JAMA. 295:676–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wright M, Woodrow G, O'Brien S, et al:
Cholecystokinin and leptin: their influence upon the eating
behaviour and nutrient intake of dialysis patients. Nephrol Dial
Transplant. 19:133–140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vignioble M, Brichard S, Jadoul M and
Goffin E: Serum leptin concentration in peritoneal dialysis
patients: determinants, longitudinal evolution and circadian
rhythm. Acta Clin Belg. 56:173–179. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsujimoto Y, Shoji T, Tabata T, et al:
Leptin in peritoneal dialysate from continuous ambulatory
peritoneal dialysis patients. Am J Kidney Dis. 34:832–838. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malyszko J, Malyszko JS and Mysliwiec M:
Visfatin and endothelial function in dialyzed patients. Nephrology
(Carlton). 15:190–196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Małgorzewicz S, Lichodziejewska-Niemierko
M, Aleksandrowicz-Wrona E, et al: Adipokines, endothelial
dysfunction and nutritional status in peritoneal dialysis patients.
Scand J Urol Nephrol. 44:445–451. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Landt M, Parvin CA, Dagogo-Jack S, et al:
Leptin elimination in hyperleptinaemic peritoneal dialysis
patients. Nephrol Dial Transplant. 14:732–737. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Johansen KL, Mulligan K, Tai V and
Schambelan M: Leptin, body composition and indices of malnutrition
in patients on dialysis. J Am Soc Nephrol. 9:1080–1084.
1998.PubMed/NCBI
|
|
39
|
Buyan N, Bideci A, Ozkaya O, et al: Leptin
and resistin levels and their relationships with glucose metabolism
in children with chronic renal insufficiency and undergoing
dialysis. Nephrology (Carlton). 11:192–196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yang FF, Lin X, Wang J and Luo ZW: Effect
observation of peritoneal dialysis on clearance of hyperleptinemia
and inflammatory factor in uremic patients. Chongqing Yi Yao.
40:34–35,37. 2011.(In Chinese).
|
|
41
|
Xu XD, Hu P, Wang NS, et al: The
relationship between leptin and nutrition status in patients with
chronic renal failure undergoing different ways of blood
purification. Xuzhou Yi Ke Da Xue. 28:85–88. 2008.(In Chinese).
|
|
42
|
Wu R, Ma K and Wang J: Analysis of serum
leptin and inflammatory cytokines in peritoneal dialysis clear
uremic patients. Chin and Foreign Health Abstract. 8:468. 2011.
|
|
43
|
Wu JQ, Zhou ZS, Pan ZX and Li HZ: An
analysis for the relationship between leptin and the nutrition
status in peritoneal dialysis patients. Zhongguo Ji Ceng Yi Yao.
13:185–186. 2006.(In Chinese).
|
|
44
|
Wang ZM, Wang Q and Yu JS: Effects of
peritoneal dialysis on indexes in patients with chronic renal
failure. Xian Dai Zhong Xi Yi Jie He Za Zhi. 19:1185–1186, 1226.
2010.(In Chinese).
|
|
45
|
Zuo J, Zou JZ, Fang Y, et al: Serum leptin
levels and malnutrition in chronic renal failure. Shanghai Yi Xue.
679–682. 2002.(In Chinese).
|
|
46
|
Ma Y, Zhao J, Sun XW, et al: Serum leptin
levels and its clinical significance in patients with different
stages of chronic renal failure. Zhong Guo Xian Dai Yi Yao Za Zhi.
13:42–45. 2011.(In Chinese).
|
|
47
|
Guan X and Zheng HG: Analysis of leptin
levels in peritoneal dialysis patients and its influencing factors.
Zhong Guo Shi Yong Nei Ke Za Zhi. 26:19–21. 2006.(In Chinese).
|
|
48
|
An WS, Son YK, Kim SE, et al: Association
of adiponectin and leptin with serum lipids and erythrocyte omega-3
and omega-6 fatty acids in dialysis patients. Clin Nephrol.
75:195–203. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hou N and Luo JD: Leptin and
cardiovascular diseases. Clin Exp Pharmacol Physiol. 38:905–913.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Díez JJ, Bossola M, Fernández-Reyes MJ, et
al: Relationship between leptin and all-cause and cardiovascular
mortality in chronic hemodialysis patients. Nefrologia. 31:206–212.
2011.PubMed/NCBI
|
|
51
|
Golembiewska E, Safranow K, Ciechanowski
K, et al: Adipokines and parameters of peritoneal membrane
transport in newly started peritoneal dialysis patients. Acta
Biochim Pol. 60:617–621. 2013.PubMed/NCBI
|
|
52
|
Beberashvili I, Sinuani I, Azar A, et al:
Longitudinal study of leptin levels in chronic hemodialysis
patients. Nutr J. 10:682011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ponce D, Caramori JT, Barretti P and Balbi
AL: Peritoneal dialysis in acute kidney injury: Brazilian
experience. Perit Dial Int. 32:242–246. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Fontán MP, Rodríguez-Carmona A, Cordido F
and García-Buela J: Hyperleptinemia in uremic patients undergoing
conservative management, peritoneal dialysis and hemodialysis: A
comparative analysis. Am J Kidney Dis. 34:824–831. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tsai JP, Tsai CC, Liu HM, et al:
Hyperleptinaemia positively correlated with metabolic syndrome in
hemodialysis patients. Eur J Intern Med. 22:e105–e109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
